The Influence of Ketogenic Diet on Lupus Nephritis Patients' Immunity
1 other identifier
interventional
30
1 country
1
Brief Summary
The study investigates the dietary habits in relation to low doses of omega-3 fatty acids in subcutaneous adipose tissue, disease activity and atherosclerosis. The low intake of omega-3 and high intake of carbohydrate among patients with SLE appear to be associated with worse disease activity, adverse serum lipids and plaque presence.Three-month-old mice received an injection of pristane or saline solution and were fed with different experimental diets: sunflower oil diet or extra virgin olive oil (EVOO) diet. After 24 weeks, mice were sacrificed, spleens were collected and kidneys were removed for immunoinflammatory detections. The study have demonstrated that EVOO diet significantly reduced renal damage and decreased cytokine: TNF-α, IL-6, IL-10 and IL-17 production.The ketogenic diet utilizes a high fat, adequate protein, low carbohydrate diet that control type of food and exchange. The aim of the present study that ketogenic diet treated in SLE patients may decrease overactive immunity and associated inflammatory markers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 10, 2023
CompletedFirst Posted
Study publicly available on registry
January 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedJanuary 19, 2023
September 1, 2022
1 year
January 10, 2023
January 18, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
urine albumin creatinine ratio
By using urine albumin creatinine ratio to determine whether the ketogenic diet could result in less proteinuria
8 times: Day1, 1st week, 1st month, 2nd month during ketogenic diet then Day1, 1st week, 1st month, 2nd month during balanced diet
Change in Inflammatory cytokine
By testing blood inflammatory cytokine: TNF-α, IL-6, IL-10 and IL-17 to evaluate whether the ketogenic diet could decrease systemic inflammation
8 times: Day1, 1st week, 1st month, 2nd month during ketogenic diet then Day1, 1st week, 1st month, 2nd month during balanced diet
Secondary Outcomes (2)
Change of subclass of T cells
2 times: 2nd month during ketogenic diet then 2nd month during balanced diet
Change of Gut microbiota analysis
2 times: 2nd month during ketogenic diet then 2nd month during balanced diet
Study Arms (2)
Patients received ketogenic diet then Balanced diet
EXPERIMENTALsubjects will be educated by dietitian and receive two months of ketogenic diet. Then, followed by three months of washout period. Finally, they will receive dietary education and follow balanced diet for two months.
Patients received Balanced diet then ketogenic diet
EXPERIMENTALsubjects will receive dietary education and follow balanced diet for two months first, then followed by three months of washout period. At last, they will receive dietary education of ketogenic diet and need to follow the ketogenic diet for two months.
Interventions
The course of the trial to medium-chain triglyceride lipid intervening 50-70% of dietary intake
Balanced diet
Eligibility Criteria
You may qualify if:
- more than 20 years old
- can accept these dietary intervention and fill out the consent
- Satisfy at least four criteria according to 1997 American College of Rheumatology Classification Criteria
- Under maintenance stage of disease and have more than 1gm of daily proteinuria.
You may not qualify if:
- Can't cooperate the diet intervention
- Rapid progression of renal function, or already need renal replacement therapy (Dialysis or kidney transplantation)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chang Gung memorial hospital
Taoyuan District, 333, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2023
First Posted
January 19, 2023
Study Start
September 1, 2022
Primary Completion
September 1, 2023
Study Completion
September 1, 2024
Last Updated
January 19, 2023
Record last verified: 2022-09